Significance of Epigenetic Alteration in Cancer-Associated Fibroblasts on the Development of Carcinoma
Open Access
- 5 October 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9695
Abstract
Cancer-associated fibroblasts (CAFs) are a key constituent of the tumor microenvironment. CAFs may affect the development of tumor cells. The critical role of CAFs in the tumor microenvironment is linked to their epigenetic modifications, as a stable yet reversible regulation of cellular phenotypes. Current evidence indicates that their formation and function are closely linked to epigenetic mechanisms. Existing research indicates that the epigenetic alteration abnormalities are triggered by metabolic cues and stabilize the acquired phenotype of CAFs. This process is associated with transcriptional changes and patient outcomes in various tumors, providing a biological rationale and translational potential for reprogramming CAFs. Understanding of epigenetic modifications in CAFs remain insufficient, while DNA methylation in CAFs can alter CAF states through multiple pathways and thereby influence tumor progression. It is necessary to investigate the unique, identifiable epigenetic signatures of CAF. As an epigenetic reader couple histone acetylation to high-output oncogenic transcription; meanwhile, noncoding RNAs modulate CAF formation and therapeutic responses via bidirectional crosstalk between tumor cells and stroma. The interactions between different epigenetic modifications and their underlying regulatory logic may play a crucial role in developing new therapeutic strategies. This review focuses on the roles of DNA methylation, histone acetylation, and enhancer reprogramming in CAFs.Keywords
Funding Information
- JSPS KAKENHI (24K02525)
This publication has 138 references indexed in Scilit:
- Identification of cancer-associated fibroblast subtypes and prognostic model development in breast cancer: role of the RUNX1/SDC1 axis in promoting invasion and metastasisCell Biology and Toxicology, 2025
- Nicotinamide N‐methyltransferase negatively regulates metastasis‐promoting property of cancer‐associated fibroblasts in lung adenocarcinomaCancer Communications, 2024
- Epigenetic regulation in cancerMedcomm, 2024
- Epigenetic regulation of cancer-associated fibroblast heterogeneityBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023
- Cancer‐associated fibroblast‐secreted miR‐421 promotes pancreatic cancer by regulating the SIRT3/H3K9Ac/HIF‐1α axisThe Kaohsiung Journal of Medical Sciences, 2022
- MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to BedsideTargeted Oncology, 2020
- Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cellsInternational Journal of Cancer, 2019
- Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategyCell Biology and Toxicology, 2019
- Loss of exosomal miR‐148b from cancer‐associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasisJournal of Cellular Physiology, 2018
- The human PKP2/plakophilin‐2 gene is induced by Wnt/β‐catenin in normal and colon cancer‐associated fibroblastsInternational Journal of Cancer, 2017